Yu Mao

Effects of programmed death-ligand 1 expression on OK-432 immunotherapy following transurethral resection in non-muscle invasive bladder cancer

Zhi‐hua Liu, Yun-lin Ye, J. Bian, 2017, Oncology letters.

UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress‐mediated apoptosis

Jong Kyong Kim, Chunsik Lee, Xionghong Tan, 2019, Molecular oncology.

Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy

Jong Kyong Kim, Chunsik Lee, Jinsheng Zheng, 2021, Cell Death & Disease.

Knockdown of SHMT2 enhances the sensitivity of gastric cancer cells to radiotherapy through the Wnt/β-catenin pathway

Yu Mao, T-G Zhang, 2022, Open life sciences.

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance

Qingli Cui, Huaimin Liu, Yan-juan Hu, 2022, Frontiers in Pharmacology.